5-4-3-2-1: Overcoming inertia in patient engagement with Paul Simms
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
5-4-3-2-1: Overcoming inertia in patient engagement with Paul Simms
-
ナレーター：
-
著者：
このコンテンツについて
This PEP Talks episode features an engaging conversation between Emma and Paul Simms, founder and chief executive of Impatient. Sponsored by Norgine, the discussion delves into the challenges and frustrations of patient engagement in the pharmaceutical industry.
Paul shares his journey and the motivation behind founding Impatient, emphasising the need for a culture of continuous experimentation and adaptation in pharma. The conversation highlights the importance of integrating patient engagement as a standard practice, removing emotional and professional barriers, and fostering a more innovative and responsive industry. Emma and Paul advocate for proactive, creative approaches to patient engagement, urging professionals to act on their ideas swiftly and decisively.